New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD will have the authority to retain and expend any funds for up to […***…] year subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan. ***Confidential Treatment Requested PHS ECT-CRADA CRADA Ref. No.02663 MODEL ADOPTED June 18, 2009
Appears in 2 contracts
Samples: Agreement (Tracon Pharmaceuticals, Inc.), Agreement (Tracon Pharmaceuticals Inc)
New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD IC will have the authority to retain and expend any funds for up to […...***…...] year subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan. ***Confidential Treatment Requested PHS ECT-CRADA CRADA Case Ref. No.02663 MODEL No. DK#12-0424_MODEL ADOPTED June 18December 8, 20092010 rev August 2012
Appears in 1 contract
Samples: Research and Development Agreement (Lumena Pharmaceuticals, Inc.)
New Commitments. Neither Party will incur new expenses related to this CRADA after expiration, mutual termination, or a notice of a unilateral termination and will, to the extent feasible, cancel all outstanding commitments and contracts by the termination date. Collaborator acknowledges that ICD will have the authority to retain and expend any funds for up to […***…] one (1) year subsequent to the expiration or termination date to cover any unpaid costs obligated during the term of the CRADA in undertaking the research and development activities set forth in the Research Plan. ***Confidential Treatment Requested PHS ECTICT-CRADA CRADA Case Ref. No.02663 No. _______ MODEL ADOPTED June 18, 2009
Appears in 1 contract
